Back to News
Market Impact: 0.15

Trump has granted clemency to several high-profile white-collar fraudsters. Could Elizabeth Holmes be next?

Elections & Domestic PoliticsLegal & LitigationCrypto & Digital AssetsRegulation & LegislationPrivate Markets & VentureHealthcare & BiotechManagement & Governance

President Trump has issued an extensive clemency push in his return to office—about 1,600 grants in his first year back—targeting many Jan. 6 defendants and an increasing number of white‑collar cases, including the pardon of Binance founder Changpeng Zhao. Elizabeth Holmes, convicted of defrauding Theranos investors and serving an original 11‑year sentence (reduced to nine years for good behavior) after reporting to prison in May 2023, filed a 2025 request for commutation following a failed appellate bid in February 2025. The pattern, including reports of Binance’s $800,000 lobbying effort for Zhao, signals elevated political risk for enforcement and regulatory policy in crypto, venture‑backed startups and healthcare diagnostics, though the clemency process remains opaque and slow.

Analysis

Market structure: The clemency trend is a small direct positive for crypto sentiment and venture-funded diagnostics startups — winners include crypto-native equities (proxy: COIN) and spot BTC/GBTC demand as perceived enforcement tail-risk falls; losers are reputationally fragile private diagnostics/healthtech names where scrutiny uncertainty keeps cost of capital elevated. Competitive dynamics: softer enforcement reduces short-term cost of doing business for risky fintech/crypto entrants, likely compressing fee spreads by 50–200bp in niche markets over 6–12 months as new entrants pressure incumbents; venture supply may increase, lifting late-stage valuations by +5–15% near term. Risk assessment: Tail risks include a bipartisan regulatory crackdown (estimated 15–25% probability over 12 months) that would reverse rallies and force ~30–60% drawdowns in levered crypto names and illiquid diagnostics SPACs. Hidden dependencies: lobbying dollars, DOJ/SEC enforcement calendars and upcoming congressional hearings (30–90 days) are key catalysts that can flip sentiment quickly; watch legislative text and subpoenas as early warning signals. Trade implications: Priority direct plays are tactical long COIN (2–3% portfolio) and spot BTC (1.5–2%) to capture sentiment improvement, paired with protective hedges (10% OTM puts). Options: buy COIN 9–12 month call spreads (debit with cap) if implied vol >35% offers >2:1 reward/risk; arbitrage: deploy size into GBTC if discount >8% to NAV. Reduce RoR exposure to small-cap diagnostics/health SPACs by 30–50% in favor of selective private-equity proxies (BX, KKR) ahead of potential reflow of venture capital. Contrarian angles: Consensus focuses on immediate crypto upside but underestimates probability of stronger regulation as a backlash — historical precedent (post-pardon policy tightening) shows initial rallies fade and enforcement increases within 6–18 months. Trade accordingly: lean into asymmetric, hedged crypto exposure (small position + puts) and exploit mispricings in illiquid diagnostics names where market still overprices narrative recovery; if congressional risk dissipates in 90 days, be ready to add to crypto/PE proxies up to an additional 2–3% portfolio weight.